Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment
10.11005/jbm.2019.26.4.213
- Author:
So Young PARK
1
;
Seong Hee AHN
;
Jun Il YOO
;
Youn Jee CHUNG
;
Yun Kyung JEON
;
Byung Ho YOON
;
Ha Young KIM
;
Seung Hun LEE
;
Jehoon LEE
;
Seongbin HONG
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.
- Publication Type:Review
- Keywords:
Bone remodeling;
Osteoporosis;
Republic of Korea
- MeSH:
Bone Density;
Bone Remodeling;
Collagen Type I;
Female;
Humans;
Korea;
Miners;
Osteoporosis;
Osteoporosis, Postmenopausal;
Republic of Korea
- From:Journal of Bone Metabolism
2019;26(4):213-224
- CountryRepublic of Korea
- Language:English
-
Abstract:
Current evidences continue to support the clinical application of bone turnover markers (BTMs) in the management of postmenopausal osteoporosis. The limitations of bone mineral density measured by dual energy X-ray absorptiomet especially emphasize the beneficial roles of BTMs, such as serum C-terminal telopeptide of type I collagen and serum procollagen type I N-propeptide, as monitoring tools to assess the responses to treatment. Therefore, the proper application and assessment of BTM in clinical practice is very important. However, their use in Korea is still insufficient. Therefore, the BTM committee has set up by the Korean Society for Bone and Mineral Research have been constituted and provided a position statement which will suggest on the clinical application of BTM for the management of postmenopausal osteoporosis in Korea.
